Prosus Aktie
38,71
EUR
-0,51
EUR
-1,30
%
38,78
EUR
-0,61
EUR
-1,54
%
Prosus jetzt ohne Ordergebühren (zzgl. Spreads) handeln beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Prosus Aktie Analyse
| 03.11.20 | Prosus Conviction Buy List | Goldman Sachs Group Inc. | |
| 02.11.20 | Prosus buy | UBS AG | |
| 30.10.20 | Prosus Hold | Jefferies & Company Inc. | |
| 30.10.20 | Prosus overweight | JP Morgan Chase & Co. | |
| 30.10.20 | Prosus Conviction Buy List | Goldman Sachs Group Inc. | |
| 22.10.20 | Prosus buy | UBS AG | |
| 15.10.20 | Prosus overweight | JP Morgan Chase & Co. | |
| 12.10.20 | Prosus overweight | Barclays Capital | |
|
Werbung
|
|||
| 22.09.20 | Prosus Conviction Buy List | Goldman Sachs Group Inc. | |
| 18.09.20 | Prosus Conviction Buy List | Goldman Sachs Group Inc. | |
| 18.08.20 | Prosus Hold | Jefferies & Company Inc. | |
| 07.08.20 | Prosus buy | UBS AG | |
| 03.07.20 | Prosus Conviction Buy List | Goldman Sachs Group Inc. | |
| 18.12.19 | Prosus Hold | HSBC | |
Werbung
Werbung